Table 6.
Impact of sex on the expression of KEGG pathways in human and mouse MGs
Ontology | M Genes ↑ | F Genes ↑ | M z-score | F z-score |
---|---|---|---|---|
Human | ||||
Pyrimidine metabolism | 3 | 1 | 4.09 | 0.57 |
N-Glycan biosynthesis | 2 | 0 | 3.91 | −0.55 |
Base excision repair | 1 | 1 | 2.35 | 1.86 |
Ribosome | 1 | 4 | 1.01 | 4.78 |
Spliceosome | 0 | 4 | −0.75 | 3.73 |
Purine metabolism | 2 | 3 | 1.64 | 2.15 |
Alzheimer’s disease | 0 | 3 | −0.85 | 2.1 |
Mouse | ||||
Metabolic pathways | 161 | 70 | 6.8 | −0.69 |
Peroxisome | 23 | 3 | 6.17 | −1.07 |
Oxidative phosphorylation | 27 | 0 | 5.35 | −2.92 |
Proteasome | 13 | 3 | 4.69 | 0 |
Lysosome | 26 | 7 | 4.68 | −0.47 |
PPAR signaling pathway | 16 | 5 | 3.54 | −0.11 |
Leukocyte transendothelial migration | 6 | 21 | −1.49 | 4.93 |
NOD-like receptor signaling pathway | 3 | 13 | −1.13 | 4.59 |
Toll-like receptor signaling pathway | 5 | 18 | −1.49 | 4.43 |
Focal adhesion | 13 | 26 | −1.24 | 3.68 |
RIG-I-like receptor signaling pathway | 5 | 12 | −0.56 | 3.51 |
Adherens junction | 5 | 12 | −0.63 | 3.4 |
KEGG pathways were selected after analyses of non-transformed data. Human pathways contained ≥ 2 genes, and those of mice ≥ 16 genes. Pathways with z-scores > 2 are highlighted in bold.